OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients
Alessandro Santaniello, Barbara Vigone, Lorenzo Beretta
Metabolism (2020) Vol. 110, pp. 154300-154300
Open Access | Times Cited: 7
Alessandro Santaniello, Barbara Vigone, Lorenzo Beretta
Metabolism (2020) Vol. 110, pp. 154300-154300
Open Access | Times Cited: 7
Showing 7 citing articles:
Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm
Nelli Morgulchik, Foteini Athanasopoulou, Edmund Chu, et al.
Interface Focus (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Nelli Morgulchik, Foteini Athanasopoulou, Edmund Chu, et al.
Interface Focus (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Apremilast Improves Endothelial Glycocalyx Integrity, Vascular and Left Ventricular Myocardial Function in Psoriasis
Ignatios Ikonomidis, George Pavlidis, Nikolaos P.E. Kadoglou, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 172-172
Open Access | Times Cited: 13
Ignatios Ikonomidis, George Pavlidis, Nikolaos P.E. Kadoglou, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 172-172
Open Access | Times Cited: 13
Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists
Mai Kawazoe, Mari Kihara, Toshihiro Nanki
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1256-1256
Open Access | Times Cited: 13
Mai Kawazoe, Mari Kihara, Toshihiro Nanki
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1256-1256
Open Access | Times Cited: 13
Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19)
Qingguang Zhang, Shuang Ling, Kaili Hu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112718-112718
Open Access | Times Cited: 8
Qingguang Zhang, Shuang Ling, Kaili Hu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112718-112718
Open Access | Times Cited: 8
Comorbidities burden and previous exposure to biological agents may predict drug survival of apremilast for psoriasis in a real‐world setting
Eirini Kapniari, Μaria Dalamaga, Evangelia Papadavid
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 9
Eirini Kapniari, Μaria Dalamaga, Evangelia Papadavid
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 9
PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia
Jan Beute, Pieter Boermans, B. Benraad, et al.
Experimental Lung Research (2021), pp. 1-12
Open Access | Times Cited: 8
Jan Beute, Pieter Boermans, B. Benraad, et al.
Experimental Lung Research (2021), pp. 1-12
Open Access | Times Cited: 8
Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases
Hoang Oanh Nguyen, Laura Tiberio, Fabrizio Facchinetti, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2254-2254
Open Access | Times Cited: 2
Hoang Oanh Nguyen, Laura Tiberio, Fabrizio Facchinetti, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2254-2254
Open Access | Times Cited: 2
